Macrophage and myofibroblast involvement in ischemic acute renal failure is attenuated by endothelin receptor antagonists
- 1 January 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 55 (1), 198-208
- https://doi.org/10.1046/j.1523-1755.1999.00253.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- [125I]‐PD151242: a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculatureBritish Journal of Pharmacology, 1994
- Reversal of postischemic acute renal failure with a selective endothelinA receptor antagonist in the rat.Journal of Clinical Investigation, 1994
- Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidneyKidney International, 1993
- Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in ratsEuropean Journal of Pharmacology, 1992
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990
- Pathophysiological role of endothelin in acute renal failureLife Sciences, 1990
- Plasma Endothelin Levels in Patients with Acute Renal FailureNew England Journal of Medicine, 1989
- Glomerular actions of endothelin in vivo.Journal of Clinical Investigation, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988